← FDA DRUG APPROVALS

FDA ANDA · ANDA204571

TESTOSTERONE

Sponsor: ACTAVIS LABS UT INC

APPLICATION
ANDA204571
TYPE
ANDA
ORIGINAL APPROVAL
2015-08-05
LATEST ACTION
2025-07-15
ROUTE
TRANSDERMAL
DOSAGE FORM
GEL, METERED
MARKETING STATUS
Prescription

Products

TESTOSTERONEPrescription
TESTOSTERONE 10MG/0.5GM ACTUATION · GEL, METERED · TRANSDERMAL

Approval history

2025-07-15Labeling · Supplement 11 · standardAP
2025-06-30Labeling · Supplement 6 · standardAP
2019-06-21Labeling · Supplement 5 · standardAP
2019-06-21Labeling · Supplement 3 · standardAP
2015-08-05UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →